Hapvida Participações e Investimentos S.A. (BOVESPA:HAPV3) signed a binding proposal to acquire Medical Medicina Cooperativa Assistencial De Limeira for approximately BRL 290 million on December 3, 2019. This initial value may be changed in future price adjustments due to a possible variation in the difference between Medical's assets and liabilities, including the cash and debt variation between August 2019 and the closing date. Transaction is subject to the successful negotiation of the respective contractual acquisition instruments and their respective formalizations, which also involve ongoing legal, accounting and operational due diligence procedures, as well as the consideration and approval of Agência Nacional de Saúde Suplementar (ANS, Brazilian private healthcare agency) and Conselho Administrativo de Defesa Econômica (Cade, Brazilian antitrust authority). Hapvida Participações e Investimentos S.A. clarifies that the transaction does not generate withdrawal rights, in accordance with applicable law and regulation. José Luis Camargo of Madrona Advogados acted as legal advisor to Hapvida Participações e Investimentos S.A. Daniel Oliveira Andreoli, Paula Pinedo and Mariana Llamazalez of Demarest Advogados acted as legal advisors to Hapvida Participações e Investimentos S.A. and Medical Medicina Cooperativa Assistencial De Limeira.